[1] [1] http://www.moh.gov.cn/wsb/pxwfb/201209/55840.shtml

[2] [2] YUSUFRZ, NAEEM R. Cytogenetic abnormalities in products of conception:a relationship revisited［J］. American Journal of Reproductive Immunology, 2015, 52(1): 88-96.

[3] [3] MOTAH M, MOUMI M, NDOUMBE A, et al. Pattern and management of meural tube defect in cameroon［J］. Open Journal of Modern Neurosurgery, 2017, 07(3): 87-102.

[4] [4] CZEIZEL A E,DUD, VERECZKEY A, et al. Folate deficiency and folic acidsupplementation:the prevention of neural-tube defects and congenital heart defects［J］. Nutrients, 2013, 5(11): 4760-4775.

[5] [5] IOLASCON A, ANDOLFO I, BARCELLINI W, et al. Recommendations for splenectomy in hereditary hemolytic anemias［J］. Haematologica, 2017, 102(8): 1304.

[6] [6] LOTHRIDGE K, FOX J, FYNAN E. Blended learning: efficient, timely and cost effective［J］. Australian Journal of Forensic Sciences, 2013, 45(4): 407-416.

[7] [7] WU Chunyan. Diagnostic value of prenatal B ultrasound scan for fetal abnormalities［J］. China Medical Equipment, 2015, 12(2): 79-82.

[8] [8] BUCKLEY F, BUCKLEY S. Wrongful deaths and rightful lives - screening for Down Syndrome［J］. Downs Syndrome Research & Practice the Journal of the Sarah Duffen Centre, 2008, 12(2): 79-86.

[9] [9] SILVERMAN N S, WAPNER R J. Chorionic villus sampling and amniocentesis［J］. Current Opinion in Obstetrics & Gynecology, 1990, 2(2): 258-264.

[10] [10] LO Y M, CORBETTA N, CHAMBERLAIN P F, et al.Presence of fetal DNA in maternal plasma and serum［J］. Lancet, 1997, 350(9076): 485-487.

[11] [11] CHIU R W, AKOLEKAR R, ZHENG Y W L, et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study［J］.Bmj, 2011, 342: c7401.

[12] [12] SCHRCK E, DU M S, VELDMAN T, et al. Multicolor spectral karyotyping of human chromosomes［J］. Science, 1996, 103(1-2): 163-168.

[13] [13] LIAO Can, PAN Min, LI Dongzhi, et al.Application of spectral karyotyping in diagnosis and prenatal diagnosis of the marker chromosome［J］. Chinese Journal of Obstetrics and Gynecology, 2008, 43(5): 321-324.

[14] [14] NORDGREN A, HEYMAN M S, SCHOUMANS J, et al.Spectral karyotyping and interphase FISH reveal abnormalities not detected by conventional G-banding. Implications for treatment stratification of childhood acute lymphoblastic leukaemia: detailed analysis of 70 cases［J］. European Journal of Haematology, 2015, 68(1): 31-41.

[15] [15] SANDALINAS M, MRQUEZC, MUNNS. Spectral karyotyping of fresh, non-inseminated oocytes［J］. Molecular Human Reproduction, 2002, 8(6): 580-585.

[16] [16] YARON Y, CARMON E, GOLDSTEIN M, et al. The clinical application of spectral karyotyping (SKY)in the analysis of prenatally diagnosed extra structurally abnormal chromosomes (ESACs)［J］. Prenatal Diagnosis, 2003, 23(1): 74-79.

[17] [17] GUANCIALFRANCHI P,CALABRESE G,MORIZIO E, et al. Identification of 14 rare marker chromosomes and derivatives by spectral karyotyping in prenatal and postnatal diagnosis.［J］. American Journal of Medical Genetics Part A, 2010, 127A(2): 144-148.

[18] [18] LIAO Can, PAN Min, LI Dongzhi, et al. Application of spectral karyotype analysis in marker chromosome diagnosis and prenatal diagnosis［C］. National Symposium on Fetal Medicine and Prenatal Diagnosis, 2007: 134-136.

[19] [19] BELAUD-ROTUREAU M A, ELGHEZAL H, BERNARDIN C, et al. Spectral karyotyping (SKY)principle, avantages and limitations［J］. Annales De Biologie Clinique, 2003, 61(2): 139.

[20] [20] IMATAKA G, ARISAKA O. Chromosome analysis using spectral karyotyping (SKY)［J］. Cell Biochemistry & Biophysics, 2012, 62(1): 13-17.

[21] [21] ZHAO Huanying, BAO Jinfeng. The principle and application of quantitative real-time PCR technology［J］. Chinese Journal of Histochemistry and Cytochemistry, 2007, 16(4): 492-497.

[22] [22] MOUSSA H, TSOCHANDARIDIS M, JEMNI-YACOUB S, et al. Fetal RhD genotyping by real time quantitative PCR in maternal plasma of RhD-negative pregnant women from the Sahel of Tunisia［J］. Annales De Biologie Clinique, 2012, 70(6): 683-688.

[23] [23] SAMURA O, SEKIZAWA A, ZHEN D K, et al.Comparison of fetal cell recovery from maternal blood using a high density gradient for the initial separation step: 1.090 versus 1.119 g/ml［J］. Prenatal Diagnosis, 2015, 20(4): 281-286.

[24] [24] MANN K, PETEK E, PERTL B. Prenatal detection of chromosome aneuploidy by quantitative fluorescence PCR［J］. Humana Press, 2008, 444(92): 141-56.

[25] [25] ZHANG X, WEI S S. Down syndrome screening using real-time fluorescent quantity PCR method［J］. Chinese Journal of Birth Health & Heredity, 2010, 18(5): 31-32.

[26] [26] EMAD A, LAMOUREUX J, OUELLET A, et al. Rapid aneuploidy detection of chromosomes 13, 18, 21, X and Y using quantitative fluorescent polymerase chain reaction with few microdissected fetal cells［J］. Fetal Diagnosis & Therapy, 2015, 38(1): 65-76.

[27] [27] HUANG Zhongjun, ZHU Jiangsheng, YIN Gengxin, et al. Rapid diagnosis of Down’s syndrome by real-time quantitative PCR［J］. Chinese Journal of Family Planning, 2012, 20(5): 346-348.

[28] [28] XIANGDONG K, LIN L, LEI S, et al. Rapid diagnosis of aneuploidy using segmental duplication quantitative fluorescent PCR［J］. Plos One, 2014, 9(3): e88932.

[29] [29] SUN L, FAN Z, LONG J, et al.Rapid prenatal diagnosis of aneuploidy for chromosomes 21, 18, 13, X, and Y using segmental duplication quantitative fluorescent PCR (SD-QF-PCR)［J］. Gene, 2017, 627: 72-78.

[30] [30] ZHANG Xuan, WEI Shengshi, XIE Shiying, et al. Down syndrome screening using real-time fluorescent quantity PCR method［J］.Chinese Journal of Birth Health & Heredity, 2010, (5): 31-32.

[31] [31] LO Y M, TSUI N B, CHIU R W, et al. Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection［J］.Nature Medicine, 2007, 13(2): 218-223.

[32] [32] YANG G, YI G C, GAO J S, et al. Prenatal detection of Down’s syndrome by SNP allelic ratio analysis［J］.Chinese Journal of Birth Health & Heredity, 2010, 18(3): 30-32.

[33] [33] RAMAN C V, KRISHNAN K S. A new type of secondary radiation (Reprinted from Nature, vol 121, pg 501-502, 1928)［J］.Current Science, 1998, 74(4): 381-381.

[34] [34] VARGIS E, WEBB C N, PARIA B C, et al. Detecting changes during pregnancy with Raman spectroscopy［C］. Biomedical Sciences and Engineering Conference, 2011, IEEE

[35] [35] O′BRIEN C M, VARGIS E, RUDIN A, et al. In vivo Raman spectroscopy for biochemical monitoring of the cervix throughout pregnancy［J］.American Journal of Obstetrics & Gynecology, 2018, 218(5): 528.e1-528.e18.

[36] [36] WU Zhihui, CUI Xiangrong, HUANG Daizheng, et al. Spectral analysis of red blood cells in umbilical cord blood and children with congenital heart disease［J］. Laser Technology, 2012, 36(2): 238-242.

[37] [37] SUN Y, XU F, ZHANG Y, et al.Metallic nanostructures assembled by DNA and related applications in surface-enhancement Raman scattering (SERS)detection［J］.Journal of Materials Chemistry, 2011, 21(42): 16675-16685.

[38] [38] HARPER M M, MCKEATING K S, FAULDS K. Recent developments and future directions in SERS for bioanalysis［J］.Physical Chemistry Chemical Physics Pccp, 2013, 15(15): 5312-5328.

[39] [39] KNEIPP K, KNEIPP H, KARTHA V B, et al. Detection and identification of single DNA base molecule using surface enhanced Raman scattering (SERS)［J］. Physical Review E(Statistical Physics Plasmas Fluids & Related Interdisciplinary Topics), 1998, 57(06): R6281-R6284.

[40] [40] MOSKOVITS M. Surface-enhanced Raman spectroscopy: a brief retrospective［J］. Journal of Raman Spectroscopy, 2010, 36(6-7): 485-496.

[41] [41] LI X, YANG T, LI C S, et al. Prenatal detection of thalassemia by cell-free fetal DNA (cffDNA)in maternal plasma using surface enhanced Raman spectroscopy combined with PCR［J］.Biomedical Optics Express, 2018, 9(7): 3167-3176.

[42] [42] KIM W, LEE S H, KIM J H, et al. Paper-based surface-enhanced Raman spectroscopy for diagnosing prenatal diseases in Women［J］. Acs Nano, 2018, 12(7): 7100-7108.

[43] [43] LIN D, ZHENG Z, WANG Q, et al.Label-free optical sensor based on red blood cells laser tweezers Raman spectroscopy analysis for ABO blood typing［J］.Optics Express, 2016, 24(21): 24750-24759.

[44] [44] LIN D, GONG T, HONG Z Y, et al. Metal carbonyls for the biointerference-free ratiometric surface-enhanced aman spectroscopy-based assay for cell-free circulating DNA of Epstein-Barr Virus in blood［J］. Analytical Chemistry, 2018, 90(12): 7139-7147.